2020
Protease associated domain of RNF43 is not necessary for the suppression of Wnt/beta-catenin signaling in human cells
RADASZKIEWICZ, Tomasz Witold a Vítězslav BRYJAZákladní údaje
Originální název
Protease associated domain of RNF43 is not necessary for the suppression of Wnt/beta-catenin signaling in human cells
Autoři
RADASZKIEWICZ, Tomasz Witold (616 Polsko, domácí) a Vítězslav BRYJA (203 Česká republika, garant, domácí)
Vydání
Cell Communication and Signaling, London, BMC, 2020, 1478-811X
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
10601 Cell biology
Stát vydavatele
Velká Británie a Severní Irsko
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 5.712
Kód RIV
RIV/00216224:14310/20:00114371
Organizační jednotka
Přírodovědecká fakulta
UT WoS
000542292400001
Klíčová slova anglicky
RNF43; Protease associated domain; Wnt signaling; LRP6; RSPO1; Dishevelled
Štítky
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 19. 10. 2020 16:59, Mgr. Marie Šípková, DiS.
Anotace
V originále
BackgroundRNF43 and its homolog ZNRF3 are transmembrane E3 ubiquitin ligases frequently mutated in many human cancer types. Their main role relays on the inhibition of canonical Wnt signaling by the negative regulation of frizzled receptors and LRP5/6 co-receptors levels at the plasma membrane. Intracellular RING domains of RNF43/ZNRF3 mediate the key enzymatic activity of these proteins, but the function of the extracellular Protease Associated (PA) fold in the inhibition of Wnt/beta-catenin pathway is controversial up-to date, apart from the interaction with secreted antagonists R-spondin family proteins shown by the crystallographic studies.MethodsIn our research we utilised cell-based approaches to study the role of RNF43 lacking PA domain in the canonical Wnt signalling pathway transduction. We developed controlled overexpression (TetON) and CRISPR/Cas9 mediated knock-out models in human cells.ResultsRNF43 Delta PA mutant activity impedes canonical Wnt pathway, as manifested by the reduced phosphorylation of LRP6, DVL2 and DVL3 and by the decreased beta-catenin-dependent gene expression. Finally, rescue experiments in the CRISPR/Cas9 derived RNF43/ZNRF3 double knock-out cell lines showed that RNF Delta PA overexpression is enough to inhibit activation of LRP6 and beta-catenin activity as shown by the Western blot and Top flash dual luciferase assays. Moreover, RNF43 variant without PA domain was not sensitive to the R-spondin1 treatment.ConclusionTaken together, our results help to understand better the mode of RNF43 tumor suppressor action and solve some discrepancies present in the field.
Návaznosti
GX19-28347X, projekt VaV |
|